Page last updated: 2024-08-24

2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Emesis

2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone has been researched along with Emesis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bedikian, AY; Bodey, GP; Burgess, MA; Yap, BS1
Bedikian, AY; Bodey, GP; Burgess, MA; Freireich, EJ1
Christ, M; Haid, M; Hatfield, A; Johnson, CM; Khandekar, JD; Lanzotti, V; Locker, GY; Merrill, JM; Miller, SJ; Reisel, H1

Other Studies

3 other study(ies) available for 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Emesis

ArticleYear
AZQ therapy in patients with disseminated malignant melanoma.
    American journal of clinical oncology, 1982, Volume: 5, Issue:6

    Topics: Adult; Aged; Anorexia; Aziridines; Azirines; Benzoquinones; Bone Marrow; Cyclohexenes; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Nausea; Thrombocytopenia; Vomiting

1982
Phase I study of aziridinylbenzoquinone (NSC 182986).
    Cancer clinical trials, 1981,Winter, Volume: 4, Issue:4

    Topics: Adult; Aged; Anemia; Aziridines; Azirines; Benzoquinones; Bone Marrow; Cyclohexenes; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Stomatitis; Thrombocytopenia; Vomiting

1981
Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A Phase II study by the Illinois Cancer Council.
    Cancer, 1985, Sep-15, Volume: 56, Issue:6

    Topics: Adolescent; Adult; Aged; Anemia; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Cyclohexenes; Drug Evaluation; Glioma; Humans; Leukopenia; Middle Aged; Nausea; Radiography; Vomiting

1985